Dong-A Socio Holdings Co Ltd (Dong-A Socio Holdings), a subsidiary of Dong-A Socio Group, operates as a holding company and its primary focus lies in managing its affiliates and providing business management services. The company operates through its subsidiaries. Dong-A ST is a pharmaceutical company dedicated to developing ethical drugs and new global treatments. Dong-A Pharmaceutical concentrates on creating innovative products and services tailored to customer needs in the healthcare sector, with key areas including Bacchus, over-the-counter (OTC) products, consumer healthcare, and cosmetics. ST Pharm offers cGMP-based services that support pharmaceutical companies in drug development and commercialization, emphasizing oligonucleotide-based therapeutics, as well as new chemical drugs and generics. STgen Bio, a biopharmaceutical manufacturer established through a partnership with Japan’s Meiji Seika Pharma, operates as a global Contract Development and Manufacturing Organization (CDMO). Dong-A Chammed specializes in medical devices for ENT (Ear, Nose, and Throat) and in vitro diagnostics, along with medical infection control solutions. Dong-A Otsuka leads in functional beverages and foods, consistently expanding its product range with offerings like Pocari Sweat and innovative zero-calorie drinks, including pineapple and green apple flavors of Narangd Cider. Yongma Logis serves as a comprehensive logistics provider, excelling in Supply Chain Management (SCM) within the Health and Beauty (H&B) sector through specialized logistics services. Soo Seok focuses on food packaging, producing glass bottles, PET bottles, aluminum and plastic caps, and paper packaging boxes. Korea Sinto is an engineering company that enhances the technological infrastructure of the automobile, heavy, and shipbuilding industries, specializing in foundry, shot blasting, pollution control, and industrial plant facilities. Dongcheonsu is committed to producing high-quality beverages and advancing research in mineral water, carbonated drinks, and mixed beverages. ABEN Engineering & Construction specializes in healthcare construction, delivering comprehensive services including civil engineering, design, and property development for diverse facilities. DA Information specializes in IT services for the Dong-A Socio Group, enhancing production facilities and ensuring stable, efficient operations across sectors such as pharmaceuticals, biotechnology, food and beverage, logistics, and construction.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Dong-A Socio Holdings emphasizes strong research and development (R&D) across its businesses through its subsidiaries. Dong-A ST is focusing on developing small molecule-based new drugs and biopharmaceuticals, targeting critical treatment areas such as cancer, immunity, neurodegenerative diseases, and more. Dong-A Pharmaceutical is advancing consumer health products, encompassing drugs, health-functional foods, cosmetics, and medical devices, while also researching new substances, including natural materials and lactic acid bacteria. ST Pharm is expanding its capabilities in gene therapy through advanced oligonucleotide-based therapeutics and mRNA CDMO infrastructure. In FY2024, the company invested KRW8,872.7 million, reflecting a 20% year-over-year increase.